 |
The impact of our system extends across three major domains. In pharmaceutical development, we enable lead optimization by predicting metabolic stability early in the development pipeline, provide structural basis for competitive inhibition analysis in DDI prediction, and support CYP polymorphism analysis for patient-specific dosing in personalized medicine. For clinical decision support, our system offers real-time metabolism prediction for new drug combinations, structural analysis for adverse reaction prevention through safety screening, and precision dosing based on enzyme structure variants. In research acceleration, we reduce experimental screening time from months to minutes, provide atomic-level precision guidance for rational drug design, and enable virtual studies before synthesis commitment. The economic impact is substantial - our system has the potential to save between 500 million to 1 billion dollars per successful drug by preventing late-stage failures due to metabolism issues. |
IEEE/ICACT20260263 Slide.04
[Big Slide]